APA

Subbiah V., Hess K. R., Khawaja M. R., Wagner M. J., Tang C., Naing A., Fu S., Janku F., Piha-Paul S., Tsimberidou A. M., Herzog C. E., Ludwig J. A., Patel S., Ravi V., Benjamin R. S., Meric-Bernstam F. & Hong D. S. (20180423). Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies. : Scientific reports.

Chicago

Subbiah Vivek, Hess Kenneth R, Khawaja Muhammad Rizwan, Wagner Michael J, Tang Chad, Naing Aung, Fu Siqing, Janku Filip, Piha-Paul Sarina, Tsimberidou Apostolia M, Herzog Cynthia E, Ludwig Joseph A, Patel Shreyaskumar, Ravi Vinod, Benjamin Robert S, Meric-Bernstam Funda and Hong David S. 20180423. Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies. : Scientific reports.

Harvard

Subbiah V., Hess K. R., Khawaja M. R., Wagner M. J., Tang C., Naing A., Fu S., Janku F., Piha-Paul S., Tsimberidou A. M., Herzog C. E., Ludwig J. A., Patel S., Ravi V., Benjamin R. S., Meric-Bernstam F. and Hong D. S. (20180423). Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies. : Scientific reports.

MLA

Subbiah Vivek, Hess Kenneth R, Khawaja Muhammad Rizwan, Wagner Michael J, Tang Chad, Naing Aung, Fu Siqing, Janku Filip, Piha-Paul Sarina, Tsimberidou Apostolia M, Herzog Cynthia E, Ludwig Joseph A, Patel Shreyaskumar, Ravi Vinod, Benjamin Robert S, Meric-Bernstam Funda and Hong David S. Evaluation of Novel Targeted Therapies in Aggressive Biology Sarcoma Patients after progression from US FDA approved Therapies. : Scientific reports. 20180423.